Intravac appoints Nathalie Laarakker as CFO

pharmafile | April 7, 2021 | Appointment | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing  

Intravac have announced the appointment of Nathalie Laarakker as its new CFO and member of the company’s executive management team.

Laarakker is an experienced CFO and finance director for multinational companies, joining Intravacc from cancer immunotherapies R&D company Gadeta, after having served as their Chief Financial Officer and Managing Director since 2018.

Laarakker said: “I am excited to be joining Intravacc at such an important and pivotal moment in the company’s development. Intravacc has gone through a couple of challenging years before it became a private company with the Dutch state as shareholder early 2021. I look forward to working with the management team and the newly established Supervisory Board and to maximising the company’s strategic and financial objectives.”

Related Content

No items found

Latest content